GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Liabilities-to-Assets

Organon Pharma Indonesia PT (ISX:SCPI) Liabilities-to-Assets : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Organon Pharma Indonesia PT's Total Liabilities for the quarter that ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT's Total Assets for the quarter that ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Liabilities-to-Assets Historical Data

The historical data trend for Organon Pharma Indonesia PT's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Liabilities-to-Assets Chart

Organon Pharma Indonesia PT Annual Data
Trend
Liabilities-to-Assets

Organon Pharma Indonesia PT Quarterly Data
Liabilities-to-Assets

Competitive Comparison of Organon Pharma Indonesia PT's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organon Pharma Indonesia PT's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Liabilities-to-Assets falls into.



Organon Pharma Indonesia PT Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Organon Pharma Indonesia PT's Liabilities-to-Assets Ratio for the fiscal year that ended in . 20 is calculated as:

Liabilities-to-Assets (A: . 20 )=Total Liabilities/Total Assets
=/
=N/A

Organon Pharma Indonesia PT's Liabilities-to-Assets Ratio for the quarter that ended in . 20 is calculated as

Liabilities-to-Assets (Q: . 20 )=Total Liabilities/Total Assets
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT  (ISX:SCPI) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Organon Pharma Indonesia PT Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines